S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

IOVA Iovance Biotherapeutics Inc

10.935

0.265 (2.48%)

Last Updated: 13:12:13

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more Iovance Biotherapeutics Charts.

Iovance Biotherapeutics (NASDAQ:IOVA)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Iovance Biotherapeutics Charts.

Iovance Biotherapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 16 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 16 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 16 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 5 September 2024 (2 months ago) • Edgar (US Regulatory)

Iovance Biotherapeutics to Present at Upcoming Conferences
Tuesday 3 September 2024 (2 months ago) • GlobeNewswire Inc.

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Friday 16 August 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 9 August 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (3 months ago) • Edgar (US Regulatory)

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
Thursday 8 August 2024 (3 months ago) • GlobeNewswire Inc.

More Iovance Biotherapeutics Inc News Articles

NLBNPIT22DW5 20241220 3.6

NLBNPIT22SU7 20241220 190

NLBNPIT1UYH4 20991231 3....

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions